Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸ ½ÉÆ÷Áö¿ò °³ÃÖ
- ÀÛ¼ºÀÚ
- °ü¸®ÀÚ
- ÀÛ¼ºÀÏ
- 2006-03-30
- Á¶È¸
- 6192
´ëÇÑÇ÷¾×ÇÐȸ »êÇÏ Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸ ½ÉÆ÷Áö¿òÀÌ ´ÙÀ½°ú °°ÀÌ °³ÃֵǿÀ´Ï ȸ¿ø ¿©·¯ºÐµéÀÇ ¸¹Àº °ü½É°ú Âü¿© ºÎŹµå¸³´Ï´Ù.
= ´ÙÀ½ =
ÀϽÃ: 2006³â 3¿ù 31ÀÏ(±Ý¿äÀÏ) ¿ÀÈÄ 2½Ã-¿ÀÈÄ 6½Ã 20ºÐ
ÁÖÁ¦: The impact of molecular study on the treatment of malignant lymphoma
Àå¼Ò: ¼¿ï´ëÇк´¿ø »ï¼º¾Ï¿¬±¸µ¿ ÀÌ°ÇÈñȦ
ÁÖ°ü: ´ëÇÑÇ÷¾×ÇÐȸ »êÇÏ Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸
¿¬¼öÆòÁ¡: 4.0 Á¡
14:00-14:10 Àλ縻¾¸ (Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸ À§¿øÀå ±è ö¼ö)
¿¬Á¦:
Á¦ 1ºÎ ÁÂÀå (¼¿ï´ëÇк´¿ø ¹Ú ¼±¾ç)
1) 14:10-14:30 Molecular aspects of histologic diagnosis (¼¿ï¾Æ»êº´¿ø Çã ÁÖ·É)
2) 14:35-14:55 DNA microarray for malignant lymphoma (¸¶Å©·ÎÁø»ç ° Á¾È£)
3) 15:00-15:20 Updated treatment of low grade non Hodgkin lymphoma (´ë±¸ÆÄƼ¸¶º´¿ø ÀÌ Á¤¸²)
Á¦ 2ºÎ ÁÂÀå (°³²¼º¸ðº´¿ø ¹Ú Á¾¿ø)
4) 15:40-16:00 Advances in the treatment of aggressive non Hodgkin B cell lymphoma (°³²¼º¸ðº´¿ø È« ¿µ¼±)
5) 16:05-16:25 Optimal treatment of T cell and/or NK cell lymphoma (¼¿ï»ï¼ºº´¿ø ±è ¿ø¼®)
6) 16:30-16:50 The role of PET scan in the lymphoma management (¼¼ºê¶õ½ºº´¿ø À± ¹ÌÁø)
Á¦ 3ºÎ ÁÂÀå (ÀÎÇÏ´ëÇк´¿ø ±è ö¼ö)
7) 17:10-17:30 Current research on Hodgkin lymphoma (»ó°è¹éº´¿ø À¯ ¿µÁø)
8) 17:35-17:55 Treatment of pediatric lymphoma (¼¼ºê¶õ½ºº´¿ø À¯ öÁÖ)
9) 18:00-18:20 Molecular targeted therapy for malignant lymphoma (¼¿ï´ëÇк´¿ø À± ¼º¼ö)
= ´ÙÀ½ =
ÀϽÃ: 2006³â 3¿ù 31ÀÏ(±Ý¿äÀÏ) ¿ÀÈÄ 2½Ã-¿ÀÈÄ 6½Ã 20ºÐ
ÁÖÁ¦: The impact of molecular study on the treatment of malignant lymphoma
Àå¼Ò: ¼¿ï´ëÇк´¿ø »ï¼º¾Ï¿¬±¸µ¿ ÀÌ°ÇÈñȦ
ÁÖ°ü: ´ëÇÑÇ÷¾×ÇÐȸ »êÇÏ Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸
¿¬¼öÆòÁ¡: 4.0 Á¡
14:00-14:10 Àλ縻¾¸ (Çѱ¹¸²ÇÁÁ¾¿¬±¸È¸ À§¿øÀå ±è ö¼ö)
¿¬Á¦:
Á¦ 1ºÎ ÁÂÀå (¼¿ï´ëÇк´¿ø ¹Ú ¼±¾ç)
1) 14:10-14:30 Molecular aspects of histologic diagnosis (¼¿ï¾Æ»êº´¿ø Çã ÁÖ·É)
2) 14:35-14:55 DNA microarray for malignant lymphoma (¸¶Å©·ÎÁø»ç ° Á¾È£)
3) 15:00-15:20 Updated treatment of low grade non Hodgkin lymphoma (´ë±¸ÆÄƼ¸¶º´¿ø ÀÌ Á¤¸²)
Á¦ 2ºÎ ÁÂÀå (°³²¼º¸ðº´¿ø ¹Ú Á¾¿ø)
4) 15:40-16:00 Advances in the treatment of aggressive non Hodgkin B cell lymphoma (°³²¼º¸ðº´¿ø È« ¿µ¼±)
5) 16:05-16:25 Optimal treatment of T cell and/or NK cell lymphoma (¼¿ï»ï¼ºº´¿ø ±è ¿ø¼®)
6) 16:30-16:50 The role of PET scan in the lymphoma management (¼¼ºê¶õ½ºº´¿ø À± ¹ÌÁø)
Á¦ 3ºÎ ÁÂÀå (ÀÎÇÏ´ëÇк´¿ø ±è ö¼ö)
7) 17:10-17:30 Current research on Hodgkin lymphoma (»ó°è¹éº´¿ø À¯ ¿µÁø)
8) 17:35-17:55 Treatment of pediatric lymphoma (¼¼ºê¶õ½ºº´¿ø À¯ öÁÖ)
9) 18:00-18:20 Molecular targeted therapy for malignant lymphoma (¼¿ï´ëÇк´¿ø À± ¼º¼ö)